Rob M. Moormann

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Journal: Frontiers in microbiology

Published: December 22, 2015

Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.

Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.

Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.)

Published: December 20, 2015

Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.

Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.

Journal: PloS one

Published: June 18, 2015

Foot-and-Mouth Disease Seroprevalence in Cattle in Eritrea.

Foot-and-Mouth Disease Seroprevalence in Cattle in Eritrea.

Journal: Transboundary and emerging diseases

Published: May 22, 2015

Preliminary Evaluation of a Bunyavirus Vector for Cancer Immunotherapy.

Preliminary Evaluation of a Bunyavirus Vector for Cancer Immunotherapy.

Journal: Journal of virology

Published: April 29, 2015

Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.

Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.

Journal: Vaccine

Published: December 09, 2014

Paramyxovirus-based production of Rift Valley fever virus replicon particles.

Paramyxovirus-based production of Rift Valley fever virus replicon particles.

Journal: The Journal of general virology

Published: September 12, 2014

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.

Journal: Vaccine

Published: August 26, 2014

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.

Journal: Journal of virology

Published: July 11, 2014

No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.

No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.

Journal: Vaccine

Published: May 19, 2014

Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen.

Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen.

Journal: Vaccine

Published: May 07, 2014

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Journal: Vaccine

Published: May 06, 2014

Showing 1-12 of 28

Last Updated: 09/26/2026